These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31175103)

  • 1. Intravenous Iron Use in the Care of Patients with Kidney Disease.
    Macdougall IC
    Clin J Am Soc Nephrol; 2019 Oct; 14(10):1528-1530. PubMed ID: 31175103
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of outpatient treatment with intravenous iron in selected primary Care patients.
    Rivilla Marugán L; Lorente Aznar T; García-Erce JA
    Med Clin (Barc); 2020 Jan; 154(2):66-67. PubMed ID: 30497767
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of Iron Dosing Strategies in Patients Undergoing Long-Term Hemodialysis: A Randomized Controlled Trial.
    Bielesz B; Lorenz M; Monteforte R; Prikoszovich T; Gabriel M; Wolzt M; Gleiss A; Hörl WH; Sunder-Plassmann G
    Clin J Am Soc Nephrol; 2021 Oct; 16(10):1512-1521. PubMed ID: 34470831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol and baseline data for a prospective open-label explorative randomized single-center comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD).
    Ziedan A; Bhandari S
    Trials; 2019 Apr; 20(1):194. PubMed ID: 30947751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Sucrosomial Iron Is as Effective as Intravenous Ferric Carboxy-Maltose in Treating Anemia in Patients with Ulcerative Colitis.
    Bertani L; Tricò D; Zanzi F; Baiano Svizzero G; Coppini F; de Bortoli N; Bellini M; Antonioli L; Blandizzi C; Marchi S
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33673371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of intravenous iron supplementation in chronic kidney disease: an update.
    Macdougall IC; Geisser P
    Iran J Kidney Dis; 2013 Jan; 7(1):9-22. PubMed ID: 23314137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial.
    Bhandari S; Kalra PA; Berkowitz M; Belo D; Thomsen LL; Wolf M
    Nephrol Dial Transplant; 2021 Jan; 36(1):111-120. PubMed ID: 32049331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a multifaceted intervention to promote the use of intravenous iron sucrose complex instead of ferric carboxymaltose in patients admitted for more than 24 h.
    Touchard J; Perrin G; Berdot S; Pouchot J; Loustalot MC; Sabatier B
    Eur J Clin Pharmacol; 2021 Feb; 77(2):189-195. PubMed ID: 32926203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial.
    Jose A; Mahey R; Sharma JB; Bhatla N; Saxena R; Kalaivani M; Kriplani A
    BMC Pregnancy Childbirth; 2019 Feb; 19(1):54. PubMed ID: 30717690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical perspective: iron replacement therapy in chronic heart failure.
    Cowie MR; Lucas R
    Int J Clin Pract; 2011 Jun; 65(6):645-8. PubMed ID: 21564435
    [No Abstract]   [Full Text] [Related]  

  • 11. Post-PIVOTAL Iron Dosing with Maintenance Hemodialysis.
    Collister D; Tangri N
    Clin J Am Soc Nephrol; 2019 Oct; 14(10):1533-1535. PubMed ID: 31182556
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for the treatment of preoperative anemia in patients with menorrhagia: An open-label, multicenter, randomized study.
    Lee S; Ryu KJ; Lee ES; Lee KH; Lee JJ; Kim T
    J Obstet Gynaecol Res; 2019 Apr; 45(4):858-864. PubMed ID: 30932300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients.
    Hofman JMG; Eisenga MF; Diepenbroek A; Nolte IM; van Dam B; Westerhuis R; Bakker SJL; Franssen CFM; Gaillard CAJM
    BMC Nephrol; 2018 Sep; 19(1):242. PubMed ID: 30236065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferric Maltol: A New Oral Iron Formulation for the Treatment of Iron Deficiency in Adults.
    Khoury A; Pagan KA; Farland MZ
    Ann Pharmacother; 2021 Feb; 55(2):222-229. PubMed ID: 32633548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Meta-analysis of Intravenous Iron Therapy for Patients With Iron Deficiency and Heart Failure.
    Osman M; Syed M; Balla S; Kheiri B; Faisaluddin M; Bianco C
    Am J Cardiol; 2021 Feb; 141():152-153. PubMed ID: 33259800
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous iron in the treatment of anemia of pregnancy. 1949.
    Govan AD; Scott JM
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123 Suppl 2():S33-5. PubMed ID: 16360540
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of efficacy and safety between intravenous ferric carboxymaltose and saccharated ferric oxide in Japanese patients with iron-deficiency anemia due to hypermenorrhea: a multi-center, randomized, open-label noninferiority study.
    Ikuta K; Hanashi H; Hirai K; Ota Y; Matsuyama Y; Shimura A; Terauchi M; Momoeda M
    Int J Hematol; 2019 Jan; 109(1):41-49. PubMed ID: 30039442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial.
    Onken JE; Bregman DB; Harrington RA; Morris D; Buerkert J; Hamerski D; Iftikhar H; Mangoo-Karim R; Martin ER; Martinez CO; Newman GE; Qunibi WY; Ross DL; Singh B; Smith MT; Butcher A; Koch TA; Goodnough LT
    Nephrol Dial Transplant; 2014 Apr; 29(4):833-42. PubMed ID: 23963731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron Treatment Strategies in Nondialysis CKD.
    Macdougall IC
    Semin Nephrol; 2016 Mar; 36(2):99-104. PubMed ID: 27236130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on intravenous iron choices.
    Larson DS; Coyne DW
    Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):186-91. PubMed ID: 24401789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.